Post-earnings recap
Reported
Thu, May 6, 2021
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Guardant Health's earnings report shows a significant EPS surprise, indicating better-than-expected performance on that front. However, the lack of revenue data and no guidance update may have contributed to the stock's decline of 3.66%. Investors may be cautious as they await clearer metrics and future expectations from the company.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.49 | N/A | +40.53% |
| Revenue | N/A | N/A | N/A |
Management appears cautiously optimistic about future developments. They emphasized their commitment to innovation and market expansion.
Management highlighted ongoing advancements in their testing technology.
They expressed confidence in long-term growth despite current challenges.